The Federal Trade Commission and the FDA have overlapping missions to investigate makers of health care applications for unfair or deceptive acts or practices and false or misleading claims, officials from both agencies said. The agencies also work together on deciding which one will take action to avoid confusion, the officials said.

Full Story:

Related Summaries